Jeremy Rich named deputy director of research at UPMC Hillman Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jeremy Rich was named deputy director of research at UPMC Hillman Cancer Center.

Rich will also serve as the Pittsburgh Foundation Chair in Personalized Cancer Therapy and a professor of neurology at the University of Pittsburgh School of Medicine. Rich will help oversee Hillman’s strategic cancer research efforts.

Rich is a board-certified neuro-oncologist and physician-scientist specializing in diagnosing and treating brain tumors, with a focus on brain metastases. He is also a brain tumor biology researcher, studying cancer stem cell clinical relevance and how they interact with the tumor microenvironment to help the cancers grow and resist current treatments.

Previously, Rich was a professor of medicine, director of the Brain Tumor Institute and co-director of the Solid Tumor Therapeutics Program at the University of California San Diego. Before that, he was chair of the Department of Stem Cell Biology and Regenerative Medicine at Cleveland Clinic.

In This Issue


President Joe Biden April 9 announced his FY2022 budgetary plans for ARPA-H—Advanced Research Projects Agency-Health—a federal entity designed to “deliver breakthroughs to find cures for cancer and other diseases.” In his initial White House budget proposal—dubbed skinny budget, or budget-lite—Biden is requesting $6.5 billion to fund ARPA-H.  “The discretionary request calls for $6.5 billion to...